A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Nebivolol Added to Antihypertensive Treatment With Lisinopril or Losartan in Patients With Hypertension.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Nebivolol Added to Antihypertensive Treatment With Lisinopril or Losartan in Patients With Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Mar 2013

At a glance

  • Drugs Nebivolol (Primary) ; Lisinopril; Losartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 20 Jan 2011 Actual end date (March 2010) added as reported by ClinicalTrials.gov.
    • 20 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top